TY - JOUR
T1 - Stimulation of insulin secretion and associated nuclear accumulation of iPLA2β in INS-1 insulinoma cells
AU - Ma, Zhongmin
AU - Zhang, Sheng
AU - Turk, John
AU - Ramanadham, Sasanka
PY - 2002
Y1 - 2002
N2 - Accumulating evidence suggests that the cytosolic calcium-independent phospholipase A2 (iPLA2β) manifests a signaling role in insulin-secreting (INS-1) β-cells. Earlier, we reported that insulin-secretory responses to cAMP-elevating agents are amplified in iPLA2β-overexpressing INS-1 cells (Ma Z, Ramanadham S, Bohrer A, Wohltmann M, Zhang S, and Turk J. J Biol Chem 276: 13198-13208, 2001). Here, immunofluorescence, immunoaffinity, and enzymatic activity analyses are used to examine distribution of iPLA2β in stimulated INS-1 cells in greater detail. Overexpression of iPLA2β in INS-1 cells leads to increased accumulation of iPLA2β in the nuclear fraction. Increasing glucose concentrations alone results in modest increases in insulin secretion, relative to parental cells, and in nuclear accumulation of the iPLA2β protein. In contrast, cAMP-elevating agents induce robust increases in insulin secretion and in time-dependent nuclear accumulation of iPLA2β fluorescence, which is reflected by increases in nuclear iPLA2β protein content and specific enzymatic activity. The stimulated effects are significantly attenuated in the presence of cell-permeable inhibitors of protein phosphorylation and glycosylation. These findings suggest that conditions that amplify insulin secretion promote translocation of β-cell iPLA2β to the nuclei, where it may serve a crucial signaling role.
AB - Accumulating evidence suggests that the cytosolic calcium-independent phospholipase A2 (iPLA2β) manifests a signaling role in insulin-secreting (INS-1) β-cells. Earlier, we reported that insulin-secretory responses to cAMP-elevating agents are amplified in iPLA2β-overexpressing INS-1 cells (Ma Z, Ramanadham S, Bohrer A, Wohltmann M, Zhang S, and Turk J. J Biol Chem 276: 13198-13208, 2001). Here, immunofluorescence, immunoaffinity, and enzymatic activity analyses are used to examine distribution of iPLA2β in stimulated INS-1 cells in greater detail. Overexpression of iPLA2β in INS-1 cells leads to increased accumulation of iPLA2β in the nuclear fraction. Increasing glucose concentrations alone results in modest increases in insulin secretion, relative to parental cells, and in nuclear accumulation of the iPLA2β protein. In contrast, cAMP-elevating agents induce robust increases in insulin secretion and in time-dependent nuclear accumulation of iPLA2β fluorescence, which is reflected by increases in nuclear iPLA2β protein content and specific enzymatic activity. The stimulated effects are significantly attenuated in the presence of cell-permeable inhibitors of protein phosphorylation and glycosylation. These findings suggest that conditions that amplify insulin secretion promote translocation of β-cell iPLA2β to the nuclei, where it may serve a crucial signaling role.
KW - Enzymatic activity
KW - Immunoaffinity
KW - Immunofluorescence
KW - Insulin secretion
KW - Nuclear localization
UR - http://www.scopus.com/inward/record.url?scp=0036086440&partnerID=8YFLogxK
U2 - 10.1152/ajpendo.00165.2001
DO - 10.1152/ajpendo.00165.2001
M3 - Article
C2 - 11882502
AN - SCOPUS:0036086440
SN - 0193-1849
VL - 282
SP - E820-E833
JO - American Journal of Physiology - Endocrinology and Metabolism
JF - American Journal of Physiology - Endocrinology and Metabolism
IS - 4 45-4
ER -